Jaguar Health Inc expected to post a loss of $2.37 a share - Earnings Preview

Jaguar Health

08/11/2024 16:23

* Jaguar Health Inc  JAGX.OQ   JAGX.O  is expected to show a
rise
in quarterly revenue when it reports  results on November 12
(estimated) for the period ending September 30 2024
    * The San Francisco California-based  company is expected to
report a 40.0% increase in revenue to $3.938 million from $2.81
million a year ago, according to the estimate from one analyst,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Jaguar Health Inc is for
a
loss of $2.37 per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Jaguar
Health Inc
is $14.50​, above​ its last closing price of $0.99. ​​​

This summary was machine generated November 8 at 16:23 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)